Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAS 102”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)Study completedNCT04923529
What this trial is testing

TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
The University of Hong Kong 28
Testing effectiveness (Phase 2)Study completedNCT03981614
What this trial is testing

Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+3 more
Academic and Community Cancer Research United 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06092242
What this trial is testing

The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
The Second Affiliated Hospital of Shandong First Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05314101
What this trial is testing

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Who this might be right for
ImmunotherapyColorectal Cancer
Fujian Cancer Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06992258
What this trial is testing

Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Criterium, Inc. 120
Early research (Phase 1)Study completedNCT02261532
What this trial is testing

A Phase I Study of TAS-102 in Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Taiho Pharmaceutical Co., Ltd. 15
Early research (Phase 1)Study completedNCT03616574
What this trial is testing

First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsAdvanced or Metastatic Colorectal Cancer (mCRC)
Holy Stone Healthcare Co., Ltd 37
Early research (Phase 1)Study completedNCT01874522
What this trial is testing

Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

Who this might be right for
Advanced Solid Tumors (Excluding Breast Cancer)
Taiho Oncology, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT05481463
What this trial is testing

Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 22
Not applicableUnknownNCT06495463
What this trial is testing

Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan

Who this might be right for
Metastatic Colorectal Cancer
Chang Gung Memorial Hospital 110
Large-scale testing (Phase 3)Study completedNCT02500043
What this trial is testing

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Who this might be right for
Refractory Metastatic Gastric Cancer
Taiho Oncology, Inc. 507
Not applicableUnknownNCT06221423
What this trial is testing

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Fudan University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Early research (Phase 1)Study completedNCT05130060
What this trial is testing

A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Colorectal Carcinoma+8 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Large-scale testing (Phase 3)Study completedNCT04737187
What this trial is testing

Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 492
Testing effectiveness (Phase 2)Study completedNCT02860546
What this trial is testing

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04808791
What this trial is testing

ITTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaAdvanced Gastric Carcinoma
AHS Cancer Control Alberta 7
Early research (Phase 1)Study completedNCT02031055
What this trial is testing

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 8
Load More Results